News from upsher-smith laboratories, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 08, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.

Upsher-Smith Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy™ XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) presented findings from a year-long, open-label extension (OLE) study (PREVAIL OLE) of...

Dec 08, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.

Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis

 A new systematic review found that consistent and well-defined terminology to describe seizure clusters, a rare seizure pattern, is necessary...

Nov 24, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.

Upsher-Smith To Present New Data At 2014 American Epilepsy Society Annual Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it will present seven abstracts at the 68th Annual Meeting of the American...

Oct 23, 2014, 10:30 ET
Upsher-Smith Laboratories, Inc.

Upsher-Smith Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the presentation of results from an in vitro study in which Qudexy™ XR...

Sep 04, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Landmark National Survey Seeks To Shed Light On Impact Of Rare Seizure Pattern In Epilepsy

 A new landmark U.S. seizure disorder survey is being commissioned by the Epilepsy Foundation (EF) to shed light on the burden of illness...

Jul 28, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

The Upsher-Smith Galaxy™ Portfolio Of Antiepileptic Drugs Now Available

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it has launched the Upsher-Smith Galaxy™, a new and growing suite...

Jul 14, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the launch of Topiramate Extended-Release Capsules, the authorized generic of...

Jul 02, 2014, 09:00 ET

Upsher-Smith Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations

Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA)...

Jun 30, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that Qudexy™ XR (topiramate) extended-release capsules is now available...

Jun 17, 2014, 09:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Qudexy™ XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia

 Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy™ XR (topiramate) extended-release capsules, a...

Jun 09, 2014, 17:19 ET
Upsher-Smith DIANA Award Presentation; Left to Right: John Gray (President & CEO, HDMA), Brad Leonard (Director of National Accounts, Upsher-Smith), Jim Maahs (Sr. Director, Commercial Operations, Upsher-Smith), David Neu (President, AmeriSourceBergen Drug Corp). (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Named Healthcare Distribution Management Association's Manufacturer Partner of the Year

 Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in...

Jun 04, 2014, 14:53 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Receives Final NDA Approval For Vogelxo™ (Testosterone) Gel CIII

 Upsher-Smith Laboratories, Inc., today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its...

Apr 29, 2014, 15:00 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 66th Annual Meeting of the American Academy of Neurology

 Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (investigational intranasal midazolam) in...

Apr 21, 2014, 11:30 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

New Data From Upsher-Smith's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy Of Neurology

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), will highlight new pooled phase 1 data from studies in healthy adults comparing the adverse...

Mar 25, 2014, 10:07 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Local Forest Lake Family Attends 2014 National Walk For Epilepsy® In Washington, D.C.

Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with the Epilepsy Foundation of Minnesota (EFMN), today announced that the Fletcher...

Mar 25, 2014, 10:04 ET
Pictured at the 2014 National Walk for Epilepsy(R): Scott Hussey, Sr. Vice President, Sales; Jordan Fletcher; Mary Melby; Callie Fletcher; Eric Hamborg, Vice President, CNS Sales; Rachael Newman; Tyler Melby; Chris Thibodeaux, Sr. Director, Therapeutic Education and Communication; Mark Evenstad, President and CEO.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Local Washington Township Family Attends 2014 National Walk for Epilepsy® In Washington, D.C.

Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with the Epilepsy Foundation of New Jersey (EFNJ), today announced that the Leaf...

Mar 24, 2014, 13:54 ET
Upsher-Smith Laboratories, Inc.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Divests Three Women's Health Products To Vertical Pharmaceuticals

Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for...

Mar 12, 2014, 11:22 ET
Qudexy XR (topiramate) extended-release capsules product logo.  (PRNewsFoto/Upsher-Smith Laboratories, Inc.)

Upsher-Smith Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug...

Mar 04, 2014, 10:30 ET

American Heart Month 2014: Committing to a Year of Heart Health

 February has passed and with its close comes the end of American Heart Month. But the end of the month should not be the end of...